Literature DB >> 31704035

Conceptual review of key themes in treating prostate cancer in older adults.

Ramy Sedhom1, Arjun Gupta2.   

Abstract

Entities:  

Keywords:  Bone health; Geriatric assessments; Prognostication; Prostate cancer; Quality; Value

Mesh：

Year:  2019        PMID： 31704035      PMCID： PMC7198355          DOI： 10.1016/j.jgo.2019.10.005

Source DB:  PubMed          Journal:  J Geriatr Oncol        ISSN： 1879-4068            Impact factor:   3.599


× No keyword cloud information.
  76 in total

1.  Cause of death in older men after the diagnosis of prostate cancer.

Authors:  Melanie Ketchandji; Yong-Fang Kuo; Vahakn B Shahinian; James S Goodwin
Journal:  J Am Geriatr Soc       Date:  2008-11-18       Impact factor: 5.562

Review 2.  Androgen deprivation therapy: evidence-based management of side effects.

Authors:  Hamed Ahmadi; Siamak Daneshmand
Journal:  BJU Int       Date:  2013-01-25       Impact factor: 5.588

3.  Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer.

Authors:  Matthew R Smith; Fred Saad; Simon Chowdhury; Stéphane Oudard; Boris A Hadaschik; Julie N Graff; David Olmos; Paul N Mainwaring; Ji Youl Lee; Hiroji Uemura; Angela Lopez-Gitlitz; Géralyn C Trudel; Byron M Espina; Youyi Shu; Youn C Park; Wayne R Rackoff; Margaret K Yu; Eric J Small
Journal:  N Engl J Med       Date:  2018-02-08       Impact factor: 91.245

4.  Abiraterone and increased survival in metastatic prostate cancer.

Authors:  Johann S de Bono; Christopher J Logothetis; Arturo Molina; Karim Fizazi; Scott North; Luis Chu; Kim N Chi; Robert J Jones; Oscar B Goodman; Fred Saad; John N Staffurth; Paul Mainwaring; Stephen Harland; Thomas W Flaig; Thomas E Hutson; Tina Cheng; Helen Patterson; John D Hainsworth; Charles J Ryan; Cora N Sternberg; Susan L Ellard; Aude Fléchon; Mansoor Saleh; Mark Scholz; Eleni Efstathiou; Andrea Zivi; Diletta Bianchini; Yohann Loriot; Nicole Chieffo; Thian Kheoh; Christopher M Haqq; Howard I Scher
Journal:  N Engl J Med       Date:  2011-05-26       Impact factor: 91.245

5.  Surrogate endpoints for prostate cancer-specific mortality after radiotherapy and androgen suppression therapy in men with localised or locally advanced prostate cancer: an analysis of two randomised trials.

Authors:  Anthony V D'Amico; Ming-Hui Chen; Mario de Castro; Marian Loffredo; David S Lamb; Allison Steigler; Philip W Kantoff; James W Denham
Journal:  Lancet Oncol       Date:  2011-11-21       Impact factor: 41.316

Review 6.  The role of anxiety in prostate carcinoma: a structured review of the literature.

Authors:  William Dale; Pinar Bilir; Misop Han; David Meltzer
Journal:  Cancer       Date:  2005-08-01       Impact factor: 6.860

7.  Comprehensive Geriatric Assessment: The Belgian Experience of Implementation in the Care of Older Adult Patients With Cancer.

Authors:  Cindy Kenis
Journal:  Clin J Oncol Nurs       Date:  2019-06-01       Impact factor: 1.027

Review 8.  Management of complications of androgen deprivation therapy in the older man.

Authors:  Supriya G Mohile; Karen Mustian; Kathryn Bylow; William Hall; William Dale
Journal:  Crit Rev Oncol Hematol       Date:  2008-10-25       Impact factor: 6.312

9.  Mortality results from a randomized prostate-cancer screening trial.

Authors:  Gerald L Andriole; E David Crawford; Robert L Grubb; Saundra S Buys; David Chia; Timothy R Church; Mona N Fouad; Edward P Gelmann; Paul A Kvale; Douglas J Reding; Joel L Weissfeld; Lance A Yokochi; Barbara O'Brien; Jonathan D Clapp; Joshua M Rathmell; Thomas L Riley; Richard B Hayes; Barnett S Kramer; Grant Izmirlian; Anthony B Miller; Paul F Pinsky; Philip C Prorok; John K Gohagan; Christine D Berg
Journal:  N Engl J Med       Date:  2009-03-18       Impact factor: 91.245

10.  Docetaxel-based chemotherapy in elderly patients (age 75 and older) with castration-resistant prostate cancer.

Authors:  Antoine Italiano; Cécile Ortholan; Stéphane Oudard; Damien Pouessel; Gwenaëlle Gravis; Philippe Beuzeboc; Emmanuelle Bompas; Aude Fléchon; Florence Joly; Jean-Marc Ferrero; Karim Fizazi
Journal:  Eur Urol       Date:  2008-08-08       Impact factor: 20.096
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.